LGALS3 and melanoma: Furthermore, galactose polymers can potentially be used to target galectin-3, which is overexpressed in some cell lines, such as the melanoma cell line A375, as was the case light responsive galactose-based glycopolymer (Table 4, Entry 26), which showed selective cytotoxicity in human melanoma cells [240].